Premium Pricing of Obesity Management Drugs and Invasive Procedures
The high cost involved in the research and development of obesity drugs as well as limited financial support are together a great challenge to the growth of the obesity management market. Additionally, longer duration of research and development activities and the inclusion of clinical trials to test the drugs increase the overall expenditure. Hence, considering the current scenario, manufacturers must be cautious and ensure investment in markets that provide better return on investments.
The risks and limitations posed by the high development cost of obesity drugs could impede the growth of the global market. The high cost of surgical procedures such as gastric bypass surgery, adjustable gastric banding, gastric sleeve surgery and intragastric balloon treatment is creating new opportunities for non-invasive fat reduction devices.
Western Countries to Witness Massive Growth in Obesity Over the Next Decade
Lifestyle diseases such as diabetes and chronic diseases are the leading cause of obesity and illness globally. According to the WHO, more than 1.9 billion adults (18+ Year) were overweight and out these over 650 million were obese. Prevalence of obesity is also growing among children of age less than 5 years, around 41 million children (> 5 yrs) were overweight in 2016, according to the WHO.
Recent project by OECD, shows steady increase in obesity rate till 2030. Countries such as England, Mexico, and the U.S. are projected to account for 35%, 39% & 47% shares of population to be obese by 2030.
Changing Consumer Perception towards Body Toning and Grooming Therapy
Greater emphasis on aesthetic appearance is one of the important factors fuelling the revenue growth of the obesity management market. A large number of people are becoming conscious about physical appearance and their body posture, leading to increasing adoption of obesity management treatments in developed regions such as the U.S. and Europe. However, some of the most common reasons for obesity operatives and procedures include reducing excess fat from the body and restoring the natural appearance of the body.
A significant share of the population in the U.S. and European countries, primarily within the age group of 25-40, are increasingly resorting to advanced aesthetic services including obesity management, thereby creating sufficient traction for obesity management drug manufacturers and service providers. Total spending on surgical procedures to enhance physical appearance is expected to rise significantly over the next few years.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
50% Price Reduction in Body Contouring Procedures
Higher cost of cosmetic procedures in the U.S. and EU countries is fueling the growth of body contouring medical tourism across ASEAN and South America. Lack of reimbursements for body contouring procedures and higher cost of treatment in the U.S. are the key factors limiting the growth of the market. People are opting for cost-effective health care solutions offered by neighbouring countries such as Mexico.
The cost of body contouring procedure in Mexico is as low as 60% of the U.S. and Canada. Asian countries such as India and Thailand are also being popular among European population. The cost of cosmetic procedures in these countries is 60% less than that of Europe.
For more such actionable insights on the potential of Non-Surgical Fat Reduction market, request a free sample copy.
Competition section of the non-surgical fat reduction market report highlights the profiles of leading companies operating in non-surgical fat reduction market based on their company market shares, key product offerings, channel strategies, market reviews, surveys, in-person, product reach and competition dashboard. Examples of some of the key players profiled in the report are Valeant Pharmaceuticals International, Inc., Allergan plc, Alma Lasers, Ltd., Cynosure, Inc., Sciton, Inc., Solta Medical Inc., Lumenis Ltd., Syneron Medical Ltd., Lutronic Corporation, Lynton Lasers Ltd., EL.En. S.p.A., & Cutera Inc.
FDA-approved product line is likely to boost the adoption of non-surgical fat reduction procedures over others. Recent approval of some of the groundbreaker technologies such as fat-freezing, high-intensity focused ultrasound, etc. are likely to hold strong market position over the forecast period. However, radiofrequency devices (Monopolar/bipolar/unipolar) & laser based non-surgical fat reduction to hold large revenue share due to ready availability. Companies operating in this market will focus on effective channel management to reach the Asian market.
Non-surgical fat reduction is a procedure used to reduce body fats with the help of different types of treatment devices, lasers, light-assisted, cryo therapy, ultrasound and radiofrequency. Non-surgical fat reduction is performed at outpatient clinics or in beauty centers. Nonsurgical liposuction procedure takes less recovery time as compared to surgical liposuction. However, these procedures are conducted on certain body areas only.
About the Report
FMI conducted a research study on the non-surgical fat reduction market for the forecast period of 2017 to 2022. The report offers a comprehensive evaluation of the business opportunities prevailing in the non-surgical fat reduction market along with insights on the competition strategies, consumer adoption, product pricing, regulatory guidelines and other macro factors.
The report also covers comprehensive attributes of various type of non-surgical fat reduction technologies and company penetration, revenue share, and market competition. The report elaborates on the macro factors influencing the non-surgical fat reduction market.
Additional Questions Answered
Some of the additional questions addressed in the report for Non-Surgical Fat Reduction market-
- What is role of regulatory authority and plastic surgery service providers in market?
- What is the revenue potential of Non-Surgical Fat Reduction over conventional invasive fat reduction procedures?
- How Non-Surgical Fat Reduction market is gaining momentum in Asia region?
- Who are the key competitors and what are their portfolios in Non-Surgical Fat Reduction market?
- What is the price point for Non-Surgical Fat Reduction devices in developed countries?
- What is the current level competition in the Non-Surgical Fat Reduction market?
For answers of all the possible questions required for gauging performance of Non-Surgical Fat Reduction market, get in touch with our expert analyst.
The report on the non-surgical fat reduction market has been carefully compiled post a rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases). The report on the non-surgical fat reduction market also embodies an overall qualitative and quantitative assessment by scrutinizing data points garnered from market participants of the non-surgical fat reduction market.
The research study on the non-surgical fat reduction market also includes top trends and macro as well as micro economic factors shaping the non-surgical fat reduction market. With this approach, the report on the non-surgical fat reduction market anticipates the industry attractiveness of every major segment over the forecast timespan.
Based on product type, the non-surgical fat reduction market is segmented into
- radiofrequency devices
- laser based devices
- ultrasound devices
The end-use segments covered are
- dermatology clinics
- beauty clinics.
The non-surgical fat reduction market has been analysed across regions of
- North America
- Eastern Europe
- Western Europe
- Latin America
- Asia Pacific Excluding Japan
- Middle East and Africa